Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jul 22:11:34.
doi: 10.1186/1472-6874-11-34.

Surgical management of stress urinary incontinence in women: safety, effectiveness and cost-utility of trans-obturator tape (TOT) versus tension-free vaginal tape (TVT) five years after a randomized surgical trial

Affiliations
Randomized Controlled Trial

Surgical management of stress urinary incontinence in women: safety, effectiveness and cost-utility of trans-obturator tape (TOT) versus tension-free vaginal tape (TVT) five years after a randomized surgical trial

Sue Ross et al. BMC Womens Health. .

Abstract

Background: We recently completed a randomized clinical trial of two minimally invasive surgical procedures for stress urinary incontinence, the retropubic tension-free vaginal tape (TVT) versus the trans-obturator tape (TOT) procedure. At one year postoperatively, we were concerned to find that a significant number of women had tape that was palpable when a vaginal examination was undertaken. Because the risk factors for adverse outcomes of tape surgery are not clearly understood, we are unable to say whether palpable tapes will lead to vaginal erosions or whether they merge into vaginal tissue. We do not know whether patients go on to have further adverse consequences of surgery, leading to additional cost to patients and healthcare system. Our current study is a 5 year follow-up of the women who took part in our original trial.

Methods/design: All 199 women who participated in our original trial will be contacted and invited to take part in the follow-up study. Consenting women will attend a clinic visit where they will have a physical examination to identify vaginal erosion or other serious adverse outcomes of surgery, undertake a standardized pad test for urinary incontinence, and complete several health-related quality of life questionnaires (15D, UDI-6, IIQ-7). Analyses will compare the outcomes for women in the TOT versus TVT groups. The cost-effectiveness of TOT versus TVT over the 5 years after surgery, will be assessed with the use of disease-specific health service administrative data and an objective health outcome measure. A cost-utility analysis may also be undertaken, based on economic modeling, data from the clinical trial and inputs obtained from published literature.

Discussion: This study is needed now, because TOT and TVT are among the most frequently conducted surgical procedures for stress urinary incontinence in Canada. Because stress urinary incontinence is so common, the impact of selecting an approach that causes more adverse events, or is less effective, will have a significant impact on individual quality of life, and societal and health care costs.

Trial registration: ClinicalTrials.gov NCT00234754. Registered October 2005.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustrative Markov model structure [53].

Similar articles

Cited by

References

    1. Health Canada Marketed Health Products Directorate. Complications associated with transvaginal implantation of surgical mesh for the treatment of stress urinary incontinence and pelvic organ prolapse (4 February 2010) http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/medeff/advisories-avis/pr... (accessed 6 July 2011)
    1. FDA Public Health Notification. Serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence (October 20, 2008) http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNo... (accessed 6 July 2011) - PubMed
    1. Minassian V, Drutz H, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Obstet Gynecol. 2002;82:327–338. - PubMed
    1. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278–83. doi: 10.1097/AOG.0b013e3181c2ce96. - DOI - PubMed
    1. Milsom I. Lower urinary tract symptoms in women. Curr Opin Urol. 2009;19(4):337–41. doi: 10.1097/MOU.0b013e32832b659d. - DOI - PubMed

Publication types

MeSH terms

Associated data